cardiac failure Flashcards

1
Q

definitoon of cardiac failure

A

Inability of the cardiac output to meet the body’s demands despite normal venous pressures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

defintion of acute cardiac failure

A

new onset acute/decompensation of HF,

characterized by pulmonary and/or peripheral oedema

with or without signs of peripheral hypoperfusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

definition of chronic cardiac failure

A

Develops or progresses slowly. Venous congestion is common but arterial pressure is well maintained until very late.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

systolic HF

A

inability of the ventricle to contract normally = reduced CO, EF <40%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

diastolic HF

A

inability of ventricle to relax and fill normally = increased filling pressures.

Typically EF is >50% – HFpEF (heart failure with preserved EF).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

low output HF

A

Cardiac output is low and fails to raise normally with exertion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

high output HF

A

rare.

output is normal or increased in the face of increased needs.

Failure occurs when cardiac output fails to meet these needs.

will occur with a normal heart, but earlier in heart disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

aetiology of low output LHF

A
  • ischemic heart disease,
  • HTN,
  • cardiomyopathy,
  • aortic valve disease,
  • mitral regurg,
  • fluid overload
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

aetiology of low output RHF

A
  • secondary to LHF,
  • infarction,
  • cardiomyopathy,
  • pul HTN/embolus/valve disease,
  • chronic lung disease (cor pulmonale),
  • tricuspid regurg,
  • constrictive pericarditis/pericardial tamponade,
  • pul stensosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

aetiology of low output biventricular failure

A

arrthmia,

cardiomyopathy (dilated/restrictive),

myocarditis,

drug toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

aetiology of low output pump failure

A

systolic +/ diastolic HF,

reduced HR (B blockers, heart block, post MI),

negatively inotropic drugs (eg most antiarrhythmic agents).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

aetiology of high output HF

A

anaemia

beriberi

pregnancy

Paget’s disease

hyperthyroidism

arteriovenous malformation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

aetiology of systolic HF

A

IHD, MI, cardiomyopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

aetiology of diastolic HF

A

ventricular hypertrophy, constrictive pericarditis, tamponade, restrictive cardio myopathy, obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is congestive cardiac failure

A

when R and L ventricular failure occur together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

effect of preload and afterload on HF

A

Excessive preload = ventricular dilatation - exacerbates pump failure.

Excessive afterload = ventricular muscle thickening (ventricular hypertrophy), = stiff walls and diastolic dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

epidemiology of HF

A

1–3% of the general population;

~10% among elderly patients (>65)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

sx of LHF

A

symptoms caused by pulmonary congestion

Dyspnoea (New York Heart Associationclassification):

  • none
  • on ordinary activities
  • on less than ordinary activities
  • at rest

poor exercise tolerance

orthopnoea

paroxysmal nocturnal dyspnoea

fatigue

nocturia

cold peripheries

weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

sx of acute LVF

A

Dyspnoea,

wheeze,

cough

pink frothy sputum

20
Q

sx of RHF

A
  • swollen ankles
  • ascites
  • fatigue
  • increased weight (from oedema)
  • reduced exercise tolerance
  • anorexia
  • nausea
  • facial engorgement
  • epistaxis
21
Q

sx of high output HF

A

initially features of RVF;

later LV F becomes evident.

22
Q

signs of LHF

A

tachycardia

tachypnoea

displaced apex beat (LV dilatation)

bilateral basal crackles

3rd heart sound - gallop rhythm: rapid ventricular filling

pansystolic murmur (functional mitral regurg)

23
Q

signs of acute LVF

A

tachypnoea

cyanosis

tachycardia

peripheral shut down

pulsus alternans

gallop rhythm

wheeze ‘cardiac asthma’

fine crackles throughout the lung

24
Q

signs of RHF

A

raised JVP

hepatomegaly

ascites

anklesacral pitting

oedema

signs of functional tricuspid regurg

25
general signs of HF
cyanosis low BP narrow pulse pressure RV heave - pul hypertension severity graded by New York Classification
26
Ix for HF
bloods CXR ECG echo Swan-Ganz catheter *if BNP and ECG normal - unlikely HF, if either not normal - need echo*
27
bloods for HF
FBC, UE, LFT, CRP, glucose, lipid, TFT in acute LVF - ABG, troponin, BNP * raised Plasma BNP suggests the diagnosis of cardiac failure. * A low plasma BNP rules out cardiac failure (90% sensitivity).
28
CXR in acute LVF
cardiomegaly (heart \>50% of thoracic width) prominent upper lobe vessels pleural effusion interstitial oedema - kerley B lines perihilar shadowing - Bat's wings fluid in fissures
29
ECG in HF
may be normal ischemic changes arrhythmia MI LVH - seen in hypertension
30
echo for HF
assess ventricular contraction MI If left ventricular ejection fraction (LVEF)\<40%: systolic dysfunction. Diastolic dysfunction: reduced compliance leading to a restrictive filling defect.
31
Swan-Ganz catheter
Allows measurements of right atrial, right ventricular, pulmonary artery, pulmonary wedge and left ventricular end-diastolic pressures.
32
complications of HF
resp failure cardiogenic shock death
33
Px of HF
Fifty per cent of patients with severe heart failure die within 2 years.
34
Mx of acute LVF
medical emergency cardiogenic shock - severe cardiac failure, low BP = need inotropes eg dopamine, dobutamine and should be managed in ITU pul oedema * **Sit up patient**, 60–100% **O2 and consider CPAP** * **diamorphine** (venodilator and anxiolytic effect) * **GTN infusion** - reduce preload * **IV furosemide** if fluid overloaded (venodilator and later diuretic effect) * monitor BP, RR, sats, urine output, ECG * treat cause
35
Mx of chronic LVF
* treat cause - eg HTN * treat exacerbating factors eg anaemia, thyroid disease, infection, raised BP * stop smoking, drinking, eat less salt, optimise weight * Annual ’flu vaccine, one-off pneumococcal vaccine. * ACEi * B blocker * loop diuretic eg furosemide and salt restriction to treat fluid overload * aldosterone antagonists * angiotensin receptor blockers * hydralazine and a nitrate (visodilators) - reduce mortality * digoxin - positive inotrope - reduces hospitalisation, doesnt improve survival * n-3 polyunsaturated fatty acids - benefit mortality * cardiac resynchronisation therapy * Avoid drugs that can adversely affect patients with heart failure due to systolic dysfunction,e.g. NSAIDs, non-dihydropyridine calcium channel blockers (i.e. diltiazem and verapamil).
36
why ACEi for HF
e.g. enalapril, perindopril, ramipril: Inhibit intracardiac renin-angiotensin system which may contribute to myocardial hypertrophy and remodelling. slow progression of the heart failure and improve survival, improve sx if LV systolic dysfunction SE - high K
37
why B blocker for HF
bisprolol or carvedilol Block the effects of chronically activated sympathetic system slow progression of the heart failure and improve survival The benefits of ACEinhibitors and b-blockers are additive.
38
why loop diuretics for HF
reduce Sx SE - reduce K, renal impairment Monitor U&E and add K+-sparing diuretic (eg spironolactone) if K+\<3.2mmol/L = predisposition to arrhythmias, concurrent digoxin therapy, or pre-existing K+-losing conditions. if refractory oedema - consider adding thiazide eg metolazone
39
aldosterone antagonists in HF
spirinolactone/eplerenone improve survival in pts with classification 3 or 4 use if still Sx, or post MI with LV systolic dysfunction Monitor K+ (may cause hyperkalaemia). * May be used to assist in the management of diuretic-induced hypokalaemia.
40
ARB in HF
candesartan added in pts with persistent symptoms despite ACE inhibitors and B blockers monitor K+ may cause hyperkalaemia
41
hydralazine and a nitrate in HF
May be added in patients (particularly in Afro-Caribbeans) with persistent symptoms despite therapy with an ACE inhibitor and b-blocker
42
cardiac resynchronisation therapy in HF
Biventricular pacing improves symptoms and survival in patients with LVEF \<=35%, cardiac dyssynchrony (QRS\>120msec) and moderate to severe symptoms despite optimal medical therapy. Most patients who meet these criteria are also candidates for an implantable cardiac defibrillator (ICD) and receive a combined device.
43
digoxin in HF
helps sx even if in sinus rhythm give in pts with LV systolic dysfunction of still sx or signs when have standard therapy (inc ACEi or B blocker) or AF monitor UE - low K = risk toxicity
44
Mx of intractable HF
* reassess cause * switch furosemide to butmetanide * minimal exertion * Na and fluid restriction * metolazone and IV furosemide * opiates and IV nitrates - relieve sx * weigh daily * frequent UE - beware low K in extremis - IV ionotropes consider cardiac resynchronisation, LV assist device or transplant
45
palliative care for HF
treat/prevent co-morbidities eg flu vaccine good nutrition tackly dyspnoiea, nausea, constipation, and low mood opiates - pain and dyspnoea ox
46
L ventricular assist devices
bridging therapy while waiting for heart transplant pump force blood through tubing from LV to aorta